BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 10525039)

  • 1. Two of the usual suspects, platelet-activating factor and its receptor, implicated in acute lung injury.
    Prescott SM; McIntyre TM; Zimmerman G
    J Clin Invest; 1999 Oct; 104(8):1019-20. PubMed ID: 10525039
    [No Abstract]   [Full Text] [Related]  

  • 2. Interactive effects of tumor necrosis factor and platelet-activating factor in the pathogenesis of glomerular injury.
    Camussi G
    Lab Invest; 1994 Apr; 70(4):435-6. PubMed ID: 8176883
    [No Abstract]   [Full Text] [Related]  

  • 3. The bioregulatory role of platelet-activating factor in intracellular processes and cell-cell interactions.
    Kulikov VI; Muzya GI
    Biochemistry (Mosc); 1998 Jan; 63(1):47-54. PubMed ID: 9526094
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Platelet-activating factor mediates acid-induced lung injury in genetically engineered mice.
    Nagase T; Ishii S; Kume K; Uozumi N; Izumi T; Ouchi Y; Shimizu T
    J Clin Invest; 1999 Oct; 104(8):1071-6. PubMed ID: 10525045
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Study of platelet activating factor by using mouse ontogenic technology].
    Kume K; Shimizu K; Ishii S
    Nihon Rinsho Meneki Gakkai Kaishi; 1996 Dec; 19(6):572-5. PubMed ID: 9081720
    [No Abstract]   [Full Text] [Related]  

  • 6. [Progress in platelet-activating factor receptor research].
    Hu GL; Guo HS
    Sheng Li Ke Xue Jin Zhan; 1997 Jan; 28(1):83-4. PubMed ID: 10921090
    [No Abstract]   [Full Text] [Related]  

  • 7. [Platelet-activating factor (PAF) receptor-related pathophysiology].
    Ishii S; Shimizu T
    Tanpakushitsu Kakusan Koso; 1999 Jun; 44(8 Suppl):1068-74. PubMed ID: 10396985
    [No Abstract]   [Full Text] [Related]  

  • 8. Immunomodulation by n-3- versus n-6-rich lipid emulsions in murine acute lung injury--role of platelet-activating factor receptor.
    Schaefer MB; Ott J; Mohr A; Bi MH; Grosz A; Weissmann N; Ishii S; Grimminger F; Seeger W; Mayer K
    Crit Care Med; 2007 Feb; 35(2):544-54. PubMed ID: 17205023
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The significance of platelet activating factor and its antagonists in bronchial asthma].
    Beume R; Kilian U
    Med Klin (Munich); 1989 Jun; 84(6):286-93. PubMed ID: 2547143
    [No Abstract]   [Full Text] [Related]  

  • 10. [Effects of platelet activating factor on blood platelets].
    Fu JM
    Sheng Li Ke Xue Jin Zhan; 1989 Jan; 20(1):40-4. PubMed ID: 2549618
    [No Abstract]   [Full Text] [Related]  

  • 11. Platelet-activating factor plays a pivotal role in the induction of experimental lung injury.
    Miotla JM; Jeffery PK; Hellewell PG
    Am J Respir Cell Mol Biol; 1998 Feb; 18(2):197-204. PubMed ID: 9476906
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of platelet-activating factor on platelets and vascular endothelium.
    Braquet P; Bourgain R; Mencia-Huerta JM
    Semin Thromb Hemost; 1989 Apr; 15(2):184-96. PubMed ID: 2546255
    [No Abstract]   [Full Text] [Related]  

  • 13. [Function of platelet activating factor in asthma].
    Ukena D; Sybrecht GW
    Dtsch Med Wochenschr; 1988 Oct; 113(42):1651-6. PubMed ID: 2846251
    [No Abstract]   [Full Text] [Related]  

  • 14. Platelet-activating factor (PAF) and blastocyst-endometrial interactions.
    Harper MJ; Kudolo GB; Alecozay AA; Jones MA
    Prog Clin Biol Res; 1989; 294():305-15. PubMed ID: 2542988
    [No Abstract]   [Full Text] [Related]  

  • 15. A platelet-activating factor receptor antagonist protects against renal function deterioration in nephrotoxic nephritis.
    Livio M; Macconi D; Morigi M; Orisio S; Benigni A; Patrono C; Remuzzi G
    Adv Prostaglandin Thromboxane Leukot Res; 1987; 17B():828-32. PubMed ID: 2823570
    [No Abstract]   [Full Text] [Related]  

  • 16. [Platelet activating factor].
    Deguchi K; Murashima S; Deguchi A
    Nihon Rinsho; 1987 May; 45(5):1115-26. PubMed ID: 3041069
    [No Abstract]   [Full Text] [Related]  

  • 17. Endotoxin-induced lung vascular injury: role of platelet activating factor, tumor necrosis factor and neutrophils.
    Chang SW
    Clin Res; 1992 Oct; 40(3):528-36. PubMed ID: 1395440
    [No Abstract]   [Full Text] [Related]  

  • 18. Downregulation of platelet-activating factor responsiveness during maturation of human dendritic cells.
    Dichmann S; Rheinen H; Panther E; Herouy Y; Czech W; Termeer C; Simon JC; Gebicke-Haerter PJ; Norgauer J
    J Cell Physiol; 2000 Dec; 185(3):394-400. PubMed ID: 11056009
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Platelet-activating factor antagonists: scientific background and possible clinical applications.
    Koltai M; Guinot P; Hosford D; Braquet PG
    Adv Pharmacol; 1994; 28():81-167. PubMed ID: 8080821
    [No Abstract]   [Full Text] [Related]  

  • 20. Molecular biology. Inflammatory activities.
    Barnes PJ
    Nature; 1991 Jan; 349(6307):284-5. PubMed ID: 1846227
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.